Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000914208-25-000032
Filing Date
2025-02-07
Accepted
2025-02-07 13:04:00
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5420
2 JOINT FILING AGREEMENT Rule13D_JointFilingAgreement.htm EX-99 5775
  Complete submission text file 0000914208-25-000032.txt   13314
Mailing Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309
Business Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Subject) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93684 | Film No.: 25600654
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)